SCENESSE : First Drug for Rare Sun Disease Received Approval from EMA
A novel drug SCENESSE® designed and developed for the debilitating genetic disorder porphyria (EPP), or absolute intolerance to sunlight by
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine